Meme Cerrahisinde Sentinel Lenf Nodu Biyopsisi ve Ultrasonografi Rehberli Nodal Değerlendirme

Müslümanoğlu M, Kayhan M. Aksiller Nodların Değerlendirilmesi. Özmen V (ed.) Meme Hastalıkları Kitabı içinde. Ankara: Güneş Tıp Kitabevleri; 2012. P. 373-385.

Park KU, Somerfield MR, Anne N, et al. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. Journal of Clinical Oncology. 2025; 43(14), 1720-1741.

Osborne MP. William Stewart Halsted: his life and contributions to surgery. Lancet Oncol. 2007; 8, 256-65.

Krag DN, AndersonSJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010; 11, 927-33.

Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet oncol. 2006; 7 , 983-90.

Zhao J, Zhou Z, Zhang W, et al. Omitting sentinel lymph node biopsy in early breast cancer: too bold or the future?. Translational Breast Cancer Research, 2025, 6: 27-36.

Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918-926

Galimberti V, Cole BF, Viale G, et al.; International Breast Cancer Study Group Trial 23 01 Investigators. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel node micrometastases (IBCSG 23 01): 10 year follow up of a randomized, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385 1393. doi:10.1016/S1470 2045(18)30380 2.

Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomized, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncology. 2014;15(12):1303-1310

Loibl S, André F, Bachelot T, et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2024;35(2):159-182.

Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA oncology, 2023, 9.11: 1557-1564.

Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer – primary result of the INSEMA trial. N Engl J Med. 2025; 392, 1051-64.

Vintraecken VM, Boersma LJ, van Roozendaal LM, et al. Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial. Radiotherapy and Oncology, 2024, 191: 110069.

Jung JG, Ahn SH, Lee S, et al. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial. BMC cancer, 2022, 22.1: 189.

Zollinger RM Jr, Zollinger RM Sr. Zollinger’in Cerrahi Atlası (8. Baskı, Özmen M, Sayek İ, çeviri ed.), Ankara-Güneş Tıp Kitabevi; 2003.p.396-405.

Cheng G, Kurita S, Torigian DA, et al. Current status of sentinel lymph-node biopsy in patients with breast cancer. European journal of nuclear medicine and molecular imaging, 2011, 38.3: 562-575.

Wilhelm AJ, Mijnhout GS, Franssen EJ. Radio-pharmaceuticals in sentinel lymph-node detection-an overview. Eur J Nucl Med, 1999, 26: 36-42.

Sevensma KE, Lewis CR. Axillary sentinel lymph node biopsy. In: StatPearls [Internet]. StatPearls Publishing, 2023.

Port ER, Garcia-Etienne CA, Park J, et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol, 2007, 14: 2209-2214.

He Z, Guo F, Liu Y, et al. Predictive value of methylene blue combined with indocyanine green in sentinel lymph node metastasis in breast cancer: a prospective pilot cohort study. Frontiers in Oncology, 2024, 14: 1433907.

Bogacz P, Pelc Z, Mlak R, et al. Sentinel lymph node biopsy in breast cancer: the role of ICG fluorescence after neoadjuvant chemotherapy. Breast Cancer Research and Treatment, 2025, 210.3: 699-707.

Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. The American journal of surgery, 2005, 189.2: 236-239.

Ferrucci M, Franceschini G, Douek M. New techniques for sentinel node biopsy in breast cancer. Translat Cancer Res ,2018, S405-S417.

Huang D, Cao W, Luo Y, et al. Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?. Frontiers in Oncology, 2024, 14: 1471443.

Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer. Ontario Health (Cancer Care Ontario) and ASCO guideline. J Clin Oncol, 2021, 39;3056-3082.

Dihge L,Grabau DA, Rasmussen RW, et al. The accuracy of preoperative axillary nodal staging in primary breast cancer by ultrasound is modified by nodal metastatic load and tumor biology. Acta Oncologica, 2016, 55.8: 976-982.

Pilewskie M, Jochelson M, Gooch JC, et al. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? J Am Coll Surg. 2016, 222(2);138-145.

Song X, Tan S, He J, et al. Intraoperative ultrasound-guided wire (IOUS-wire) localization biopsy versus preoperative fine needle aspiration cytology (FNAC) for early breast cancer with clinically positive nodes, a retrospective cohort study. World Journal of Surgical Oncology, 2025, 23.1: 291.

Lim GH, Al Shukairi AM, Lee YS, et al. Targeted axillary dissection in breast cancer patients with metastatic nodal disease: a prospective study on localization techniques and oncological outcomes. Gland Surgery, 2025 14(8);1529-1538.

Kumar R, Jana S, Heiba SI, et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. Journal of Nuclear Medicine, 2003, 44.1: 7-10.

Goyal A, Newcombe RG, Mansel RE, et al. Sentinel lymph node biopsy in patients with multifocal breast cancer. European Journal of Surgical Oncology (EJSO), 2004, 30.5: 475-479.

Zahwe M, Ghzaiel BS, Najia A, et al. Performance of sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: systematic review and meta-analysis. International Journal of Surgery, 2025, 111.4: 3040-3050.

Faur IF, Dobrescu A, Clim IA, et al. Sentinel Lymph Node Biopsy in Breast Cancer Using Different Types of Tracers According to Molecular Subtypes and Breast Density—A Randomized Clinical Study. Diagnostics, 2024, 14.21: 2439.

Weaver, DL. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Modern Pathology, 2010, 23:26-32.

Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using targeted axillary dissection. JAMA Surgery. 2016;151(5):1-8.

Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast cancer research and treatment, 2006, 99.2: 203-208.

Wilke LG, McCall LM, Posther KE, et al. Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial: LG WILKE ET AL. Annals of surgical oncology, 2006,13(4), 491-500.

Bakri NAC, Kwasnicki RM, Khan N, et al. Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systematic review and meta-analysis. Annals of surgery, 2023,277(4), 572-580.

Schrenk P, Rehberger W, Shamiyeh A, et al. Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node?. Journal of surgical oncology, 2002, 80.3: 130-136.